Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose aescin for prevention of postoperative sore throat
TCTR20190903005Phase 3Completed
- Sponsor
- HRH Princess Maha Chakri Sirindhorn Medical Center
- Start
- Aug 2019
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escin in Post-extubation sore throat (POST), sponsored by HRH Princess Maha Chakri Sirindhorn Medical Center. Started Aug 2019; status: completed.
02
Drugs
escin
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on TCTR20190903005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190903005.